糖尿病与COVID-19大流行
综述总结糖尿病患者感染急性COVID-19的影响,讨论大流行期间糖尿病酮症酸中毒和新发糖尿病的表现与流行病学变化,以及大流行对患者和医疗服务的广泛影响,并就恢复阶段患者优先排序和未来保护提出建议。
要点
- 糖尿病患者感染SARS-CoV-2后住院和死亡风险增加。
- 大流行期间糖尿病酮症酸中毒和新发糖尿病的表现与流行病学发生变化。
- 短期间接影响体现在医疗服务提供上,直接感染者的病毒效应持续存在。
核心结论
- 糖尿病患者在COVID-19大流行中受到直接和间接的空前影响,需在恢复阶段优先考虑并加强未来保护。
研究设计与样本
- 综述,总结急性COVID-19对糖尿病患者的影响及大流行期间表现与流行病学变化。
主要发现
- 糖尿病患者感染SARS-CoV-2后住院和死亡风险增加。
- 大流行期间糖尿病酮症酸中毒和新发糖尿病的表现与流行病学发生变化。
- 短期间接影响体现在医疗服务提供上,直接感染者的病毒效应持续存在。
临床怎么用
- 作者建议在进入恢复阶段时对患者进行优先排序,并保护糖尿病患者以应对COVID-19可能成为地方性流行。
局限性
- 大流行初期无高质量研究证据,国家和国际共识建议随后基于观察性研究快速更新。
- 存在一些不确定性领域。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus emerged, it was evident that people with chronic diseases, including diabetes, were disproportionately affected, with an increased risk of hospitalisation and mortality. Over the ensuing 2 years, the indirect effects of the pandemic on healthcare delivery in the short term have become prominent, along with the lingering effects of the virus in those directly infected. In the wake of the pandemic and without any evidence from high quality studies, a number of national and international consensus recommendations were published, which were subsequently rapidly updated based on observational studies. There have been unprecedented disruptions from both direct and indirect impacts of coronavirus disease-2019 (COVID-19) in people with diabetes. In this review, we summarise the impact of acute COVID-19 in people with diabetes, discuss how the presentation and epidemiology during the pandemic, including presentation of diabetic ketoacidosis and new-onset diabetes, has changed, and we consider the wider impact of the pandemic on patients and healthcare service delivery, including some of the areas of uncertainty. Finally, we make recommendations on prioritising patients as we move into the recovery phase and also how we protect people with diabetes for the future, as COVID-19 is likely to become endemic.
引用
- Khunti K, Valabhji J, Misra S, et al. Diabetes and the COVID-19 pandemic. Diabetologia. 2022. PMID: 36418578. doi:10.1007/s00125-022-05833-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。